Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Scientific and Technical Instruments

Novanta, Inc. designs, develops, manufactures, and sells precision photonics and motion control components and subsystems. The Company offers its products to original equipment manufactures in the medical equipment and advanced industrial technology markets.
Website: novanta.com



Growth: Good revenue growth rate 10.4%, there is acceleration compared to average historical growth rates 5.1%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is positive, +15.0%. On average the margin is decreasing unsteadily. In the last quarter the company beat the estimated EPS, +15.6%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.07 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 14.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 24.7% higher than minimum and 33.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.6x by EV / Sales multiple , the company can be 52.5% overvalued

Insiders: For the last 3 months insiders sold company shares on $0.1 mln (-0.002% of cap.)

Key Financials (Download financials)

Ticker: NOVT
Share price, USD:  (-15.6%)123.71
year average price 139.47  


year start price 110.40 2025-11-12

min close price 99.22 2025-11-20

max close price 168.75 2026-08-17

current price 123.71 2026-11-11
Common stocks: 41 009 000

Dividend Yield:  0.0%
FCF Yield LTM: 14.9%
EV / LTM EBITDA: 35.8x
EV / EBITDA annualized: 42.3x
Last revenue growth (y/y):  +10.4%
Last growth of EBITDA (y/y):  +10.0%
Historical revenue growth:  +5.1%
Historical growth of EBITDA:  -0.7%
EV / Sales: 5.4x
Margin (EBITDA LTM / Revenue): 15.0%
Fundamental value created in LTM:
Market Cap ($m): 5 986
Net Debt ($m): -433
EV (Enterprise Value): 5 553
Price to Book: 7.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-22businesswire.com

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026

2025-11-12seekingalpha.com

5 Tech And Consumer Stocks At Risk Of Steep Declines

2025-10-27zacks.com

Novanta (NOVT) Surges 8.3%: Is This an Indication of Further Gains?

2025-10-26fool.com

Growth Fund Sells $20 Million in Novanta Stock as Headwinds Weigh on Returns

2025-05-06seekingalpha.com

Novanta Inc. (NOVT) Q1 2025 Earnings Call Transcript

2025-05-06zacks.com

Novanta (NOVT) Q1 Earnings Beat Estimates

2024-12-19businesswire.com

Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025

2024-12-18businesswire.com

Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025

2024-11-05seekingalpha.com

Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript

2024-11-05zacks.com

Novanta (NOVT) Q3 Earnings Miss Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-26 2025-06-27 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-03 2025-08-05 2024-11-05 2024-08-06 2024-05-07 2023-11-07 2023-08-08 2023-05-09 2022-11-08
acceptedDate 2025-11-03 17:11:22 2025-08-05 09:31:01 2025-02-25 09:30:35 2024-11-05 09:30:26 2024-08-06 09:30:29 2024-05-07 09:31:12 2024-02-28 09:30:49 2023-11-07 09:30:56 2023-08-08 09:34:53 2023-05-09 09:31:33 2023-03-01 09:47:22 2022-11-08 09:31:04 2022-03-01 09:29:30 2021-03-01 09:55:31
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 248M 241M 949M 244M 236M 231M 882M 222M 229M 219M 861M 223M 707M 591M
costOfRevenue 137M 134M 528M 135M 139M 136M 482M 120M 125M 121M 482M 125M 406M 346M
grossProfit 111M 107M 422M 109M 97M 95M 400M 102M 104M 98M 378M 98M 300M 245M
grossProfitRatio 0.448 0.443 0.447 0.41 0.41 0.459 0.454 0.446 0.441
researchAndDevelopmentExpenses 24M 25M 96M 23M 24M 23M 92M 22M 23M 23M 86M 21M 73M 61M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 51M 47M 176M 44M 45M 44M 164M 40M 42M 41M 159M 40M 129M 110M
otherExpenses 14M 19M 40M 9M -55 000 -116 000 33M -189 000 -191 000 5M 31M 6M 35M 18M
operatingExpenses 89M 92M 311M 77M 69M 67M 289M 67M 71M 69M 275M 68M 236M 189M
costAndExpenses 226M 226M 839M 212M 208M 203M 771M 187M 196M 190M 758M 193M 643M 535M
interestIncome 0 0 0 0 0 0 0 7M 7M 0 0 0 0 0
interestExpense 6M 6M 31M 8M 8M -8M 26M -7M -7M -6M 16M -4M 7M 7M
depreciationAndAmortization 16M 16M 56M 14M 14M 13M 47M 11M 12M 17M 53M 14M 43M 38M
ebitda 37M 43M 180M 46M 42M 41M 170M 51M 47M 43M 161M 43M 125M 98M
ebitdaratio 0.151 0.179 0.19 0.18 0.177 0.23 0.203 0.197 0.193
operatingIncome 22M 15M 111M 33M 28M 28M 110M 30M 32M 26M 103M 29M 64M 56M
operatingIncomeRatio 0.088 0.062 0.133 0.12 0.121 0.137 0.14 0.12 0.129
totalOtherIncomeExpensesNet -6M -9M -32M -8M -9M -11M -27M -5M -1M -7M -16M -2M -8M -7M
incomeBeforeTax 16M 6M 79M 24M 17M 17M 84M 23M 25M 20M 87M 27M 56M 48M
incomeBeforeTaxRatio 0.064 0.024 0.099 0.073 0.073 0.104 0.11 0.09 0.12
incomeTaxExpense 5M 1M 15M 5M 3M 2M 11M 2M 4M 1M 13M 4M 6M 4M
netIncome 11M 4M 64M 19M 14M 15M 73M 21M 21M 18M 74M 22M 50M 45M
netIncomeRatio 0.043 0.019 0.079 0.058 0.064 0.096 0.091 0.083 0.101
eps 0.3 0.12 1.78 0.53 0.38 0.41 2.03 0.59 0.58 0.51 2.08 0.63 1.42 1.27
epsdiluted 0.3 0.12 0.53 0.38 0.41 0.59 0.58 0.51 0.63
weightedAverageShsOut 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 35M 35M
weightedAverageShsOutDil 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M 36M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-28 2023-03-01 2022-03-01 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -31M -26M -16M -7M -7M
ebit 124M 123M 107M 82M 60M
nonOperatingIncomeExcludingInterest -14M -13M -4M -18M -4M
netIncomeFromContinuingOperations 64M 73M 74M 50M 45M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 64M 73M 74M 50M 45M
epsDiluted 1.77 2.02 2.06 1.41 1.25

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-26 2025-06-27 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-03 2025-08-05 2024-11-05 2024-08-06 2024-05-07 2023-11-07 2023-08-08 2023-05-09 2022-11-08
acceptedDate 2025-11-03 17:11:22 2025-08-05 09:31:01 2025-02-25 09:30:35 2024-11-05 09:30:26 2024-08-06 09:30:29 2024-05-07 09:31:12 2024-02-28 09:30:49 2023-11-07 09:30:56 2023-08-08 09:34:53 2023-05-09 09:31:33 2023-03-01 09:47:22 2022-11-08 09:31:04 2022-03-01 09:29:30 2021-03-01 09:55:31
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 89M 110M 114M 93M 98M 94M 105M 76M 91M 83M 100M 85M 117M 125M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 89M 110M 114M 93M 98M 94M 105M 76M 91M 83M 100M 85M 117M 125M
netReceivables 171M 161M 151M 165M 145M 151M 139M 148M 148M 143M 138M 146M 116M 75M
inventory 180M 168M 145M 154M 160M 161M 149M 154M 163M 167M 168M 163M 126M 93M
otherCurrentAssets 29M 23M 24M 26M 21M 23M 21M 13M 12M 12M 15M 15M 15M 11M
totalCurrentAssets 468M 462M 434M 437M 425M 429M 415M 391M 414M 405M 421M 408M 374M 304M
propertyPlantEquipmentNet 163M 163M 156M 164M 158M 158M 148M 144M 147M 146M 147M 139M 136M 113M
goodwill 648M 649M 584M 594M 587M 590M 485M 478M 483M 483M 479M 465M 480M 286M
intangibleAssets 193M 204M 186M 198M 207M 215M 145M 151M 161M 169M 176M 179M 221M 149M
goodwillAndIntangibleAssets 841M 853M 770M 792M 794M 805M 630M 629M 644M 651M 655M 644M 700M 435M
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 27M 27M 23M 19M 16M 13M 28M 25M 21M 18M 15M 12M 12M 10M
otherNonCurrentAssets 6M 6M 6M 6M 6M 5M 6M 6M 6M 6M 4M 6M 6M 3M
totalNonCurrentAssets 1 037M 1 049M 955M 982M 974M 982M 811M 803M 818M 821M 821M 800M 854M 561M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 1 506M 1 511M 1 389M 1 419M 1 399M 1 411M 1 226M 1 194M 1 233M 1 226M 1 241M 1 208M 1 228M 865M
accountPayables 100M 89M 77M 69M 71M 71M 57M 64M 65M 66M 75M 80M 69M 43M
shortTermDebt 17M 16M 15M 16M 15M 15M 14M 14M 13M 13M 13M 13M 13M 21M
taxPayables 4M 13M 16M 15M 13M 11M 8M 7M 7M 14M 14M 8M 5M 6M
deferredRevenue 8M 7M 6M 24M 7M 6M 6M 7M 6M 7M 8M 7M 7M 6M
otherCurrentLiabilities 58M 58M 25M 57M 47M 59M 22M 54M 51M 56M 19M 59M 66M 25M
totalCurrentLiabilities 187M 182M 168M 157M 153M 151M 139M 138M 136M 142M 165M 158M 184M 114M
longTermDebt 489M 498M 412M 499M 522M 509M 349M 391M 449M 463M 431M 484M 429M 195M
deferredRevenueNonCurrent 0 0 0 0 45M 47M 0 5M 5M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 20M 21M 13M 14M 14M 15M 16M 14M 16M 17M 17M 17M 34M 24M
otherNonCurrentLiabilities 9M 9M 6M 7M 7M 7M 6M 792 000 958 000 6M 6M 408M 9M 16M
totalNonCurrentLiabilities 517M 528M 475M 520M 543M 577M 413M 411M 471M 485M 499M 507M 523M 274M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 43M 44M 44M 57M 55M 47M 41M 51M 54M 52M 45M 54M 51M 39M
totalLiabilities 704M 710M 643M 677M 697M 729M 553M 549M 607M 628M 664M 665M 707M 388M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 424M 424M 424M 424M 424M 424M 424M 424M 424M 424M 424M 424M 424M 424M
retainedEarnings 304M 293M 268M 251M 232M 218M 203M 191M 170M 149M 131M 115M 57M 6M
accumulatedOtherComprehensiveIncomeLoss -3M -1M -30M -13M -27M -28M -24M -33M -25M -27M -32M -49M -13M -12M
othertotalStockholdersEquity 76M 85M 80M 74M 68M 63M 57M 52M 52M
totalStockholdersEquity 801M 801M 746M 742M 702M 682M 673M 645M 626M 598M 578M 542M 521M 477M
totalEquity 801M 801M 746M 742M 702M 682M 673M 645M 626M 598M 578M 542M 521M 477M
totalLiabilitiesAndStockholdersEquity 1 506M 1 511M 1 419M 1 399M 1 411M 1 194M 1 233M 1 226M 1 208M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 1 506M 1 511M 1 389M 1 419M 1 399M 1 411M 1 226M 1 194M 1 233M 1 226M 1 241M 1 208M 1 228M 865M
totalInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalDebt 505M 513M 471M 514M 537M 570M 405M 404M 462M 476M 489M 497M 493M 255M
netDebt 416M 403M 357M 422M 439M 477M 300M 328M 371M 393M 389M 412M 376M 130M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-28 2023-03-01 2022-03-01 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 151M 139M 138M 116M 75M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 93M 65M 89M 73M 49M
otherPayables 16M 8M 14M 5M 6M
accruedExpenses 28M 33M 36M 25M 13M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 44M 41M 45M 51M 39M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 84M 70M 55M 54M 59M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-26 2025-06-27 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT NOVT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-03 2025-08-05 2024-11-05 2024-08-06 2024-05-07 2023-11-07 2023-08-08 2023-05-09 2022-11-08
acceptedDate 2025-11-03 17:11:22 2025-08-05 09:31:01 2025-02-25 09:30:35 2024-11-05 09:30:26 2024-08-06 09:30:29 2024-05-07 09:31:12 2024-02-28 09:30:49 2023-11-07 09:30:56 2023-08-08 09:34:53 2023-05-09 09:31:33 2023-03-01 09:47:22 2022-11-08 09:31:04 2022-03-01 09:29:30 2021-03-01 09:55:31
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 11M 4M 64M 19M 14M 15M 73M 21M 21M 18M 74M 22M 50M 45M
depreciationAndAmortization 16M 16M 56M 14M 14M 13M 47M 11M 12M 12M 53M 13M 43M 38M
deferredIncomeTax 0 -3M -16M -4M -4M -4M -15M -5M -4M -4M -19M -5M -4M -4M
stockBasedCompensation 7M 7M 23M 6M 6M 6M 26M 6M 6M 6M 23M 6M 26M 23M
changeInWorkingCapital -23M -3M 19M -14M 6M -2M -21M 6M -11M -25M -45M -22M -27M 40M
accountsReceivables -10M 10M -6M -17M 5M -4M -127 000 193 000 -4M -3M -23M -17M -25M 18M
inventory -13M -14M 5M 9M -3M -4M 11M 4M 1M 52 000 -49M -13M -19M 22M
accountsPayables 0 0 13M -9M 2M 7M -20M 5M -7M -22M 30M 9M 25M -14M
otherWorkingCapital 423 000 799 000 7M 2M 2M -764 000 -12M -3M -1M 54 000 -3M -1M -7M 14M
otherNonCashItems -2M -6M 13M 2M 34M 29M 11M 5M 2M 3M 4M 409 000 6M -1M
netCashProvidedByOperatingActivities 8M 15M 159M 23M 40M 24M 120M 45M 26M 10M 91M 15M 95M 140M
investmentsInPropertyPlantAndEquipment -4M -3M -17M -4M -5M -6M -20M -7M -3M -4M -20M -2M -22M -11M
acquisitionsNet -1M -63M -191M 0 1M -191M 0 0 0 0 -22M -22M -285M 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 -585 192 0 0 0 0 0 -1M
netCashUsedForInvestingActivites -5M -67M -4M -4M -198M -7M -3M -4M -26M
debtRepayment -8M 59M -29M -31M -162M -52M -15M -15M -25M
commonStockIssued 0 0 0 0 0 0 0 0 0
commonStockRepurchased -15M -112 578 0 9M -476 000 -8M 0 -163 000 -407 000 0 -10M 0 0 -6M
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -643 000 -4M 335 540 -179 000 -176 000 -252 000 -157 000 -10M 24M
netCashUsedProvidedByFinancingActivities -23M 55M -28M -32M 162M -52M -16M -25M -1M
effectOfForexChangesOnCash -365 000 524 000 2M 4M 813 000 -208 000 3M -1M 2M 1M -5M -4M -335 000 3M
netChangeInCash -21M 4M 9M -6M 5M -12M 5M -15M 9M -17M -17M -16M -8M 46M
cashAtEndOfPeriod 89M 110M 114M 93M 98M 94M 105M 76M 91M 83M 100M 85M 117M 125M
cashAtBeginningOfPeriod 110M 106M 105M 98M 94M 105M 100M 91M 83M 100M 117M 100M 125M 79M
operatingCashFlow 8M 15M 159M 23M 40M 24M 120M 45M 26M 10M 91M 15M 95M 140M
capitalExpenditure -4M -3M -17M -4M -5M -6M -20M -7M -3M -4M -20M -2M -22M -11M
freeCashFlow 4M 12M 141M 19M 35M 18M 100M 38M 23M 7M 71M 13M 72M 130M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-28 2023-03-01 2022-03-01 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 173 000 69 000 -1M 200 000 -3M
netCashProvidedByInvestingActivities -208M -20M -43M -307M -13M
netDebtIssuance 67M -87M 11M 239M -35M
longTermNetDebtIssuance 0 0 0 -9M -35M
shortTermNetDebtIssuance 67M -87M 11M 248M 0
netStockIssuance 0 0 -22M 0 -6M
netCommonStockIssuance 0 0 -10M 0 -6M
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 -12M 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -10M -11M -49M -34M -43M
netCashProvidedByFinancingActivities 57M -98M -60M 205M -84M
incomeTaxesPaid 21M 37M 20M 11M 6M
interestPaid 33M 25M 14M 6M 6M

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-05 ET (fiscal 2025 q2)
2025 q1
2025-05-06 ET (fiscal 2025 q1)
2024 q4
2025-02-25 ET (fiscal 2024 q4)
2024 q3
2024-11-05 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-14 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2022-11-12 ET (fiscal 2022 q3)
2022 q2
2022-08-14 ET (fiscal 2022 q2)
2022 q1
2022-05-10 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-08-05 ET
Novanta Announces Financial Results for the Second Quarter 2026
2026-07-27 ET
Novanta Completes Acquisition of Riverpoint Medical
2026-07-14 ET
Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call
2026-06-22 ET
Novanta to Present at the CJS Securities 26th Annual New Ideas Summer Conference on Thursday, July 9, 2026
2026-06-09 ET
Novanta Inc. Announces $300 Million Private Placement
2026-06-09 ET
Novanta Inc. Announces Acquisition of Riverpoint Medical
2026-05-15 ET
Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
2026-05-15 ET
Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026
2026-05-11 20:45 ET
Novanta Announces Financial Results for the First Quarter 2026
2026-04-14 ET
Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call
2026-03-16 ET
Novanta Joins NVIDIA Halos AI Systems Inspection Lab
2026-02-23 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
2026-01-22 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026
2025-12-18 ET
Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026
2025-12-15 ET
Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026
2025-11-07 ET
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
2025-11-05 ET
Novanta Inc. Announces Offering of Tangible Equity Units
2025-11-03 22:00 ET
Novanta Announces Financial Results for the Third Quarter 2025
2025-10-28 ET
Novanta to Present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025
2025-10-24 ET
Novanta Hosts ISO event for Humanoid Robot Safety Standards
2025-10-21 ET
Novanta to Present at the Baird 2025 Global Industrial Conference on Tuesday, November 11, 2025
2025-10-07 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 4, 2025
2025-09-18 ET
Novanta’s Board of Directors Authorizes Additional $200 Million for Share Repurchase Program
2025-08-12 ET
Novanta to Present at Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025
2025-08-05 ET
Novanta Announces Financial Results for the Second Quarter 2025
2025-07-08 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
2025-06-12 ET
Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025
2025-05-15 ET
Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
2025-05-13 ET
Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025
2025-05-06 ET
Novanta Announces Financial Results for the First Quarter 2025
2025-04-08 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025
2025-02-25 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
2025-01-28 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025
2024-12-19 ET
Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
2024-12-18 ET
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
2024-11-05 11:59 ET
Novanta Announces Financial Results for the Third Quarter 2024
2024-10-15 21:00 ET
Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024
2024-10-08 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2024
2024-08-06 10:59 ET
Novanta Announces Financial Results for the Second Quarter 2024
2024-08-05 20:00 ET
Novanta to Present at Baird's 2024 Global Healthcare Conference on Tuesday, September 10, 2024
2024-07-09 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 6, 2024
2024-06-18 18:43 ET
Novanta to Present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024
2024-05-07 10:59 ET
Novanta Announces Financial Results for the First Quarter 2024
2024-05-01 21:00 ET
Novanta to Present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024
2024-04-19 19:48 ET
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
2024-04-09 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024
2024-02-28 11:59 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
2024-01-29 22:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, February 28, 2024
2024-01-02 21:15 ET
Novanta completes acquisition of Motion Solutions
2023-12-13 22:00 ET
Novanta to Present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024
2023-12-11 22:00 ET
Novanta to Present at the J.P. Morgan 42nd Annual Healthcare Conference on Wednesday, January 10, 2024
2023-11-14 21:13 ET
Novanta announces agreement to acquire Motion Solutions
2023-11-07 11:59 ET
Novanta Announces Financial Results for the Third Quarter 2023
2023-10-11 21:00 ET
Novanta to Present at the Baird 2023 Global Industrial Conference on Wednesday, November 8, 2023
2023-10-10 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 7, 2023
2023-08-09 14:22 ET
Novanta to Present at Baird's 2023 Global Healthcare Conference on Wednesday, September 13, 2023
2023-08-08 10:59 ET
Novanta Announces Financial Results for the Second Quarter 2023
2023-07-27 21:00 ET
Novanta receives Silver rating from EcoVadis
2023-07-11 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 8, 2023
2023-06-26 21:00 ET
Novanta to Present at the CJS Securities 23rd Annual New Ideas Summer Conference on Tuesday, July 11, 2023
2023-05-22 21:00 ET
Novanta to Present at Baird's 2023 Global Consumer, Technology & Services Conference on Wednesday, June 7, 2023
2023-05-17 21:00 ET
Novanta to Present at the William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023
2023-05-09 10:59 ET
Novanta Announces Financial Results for the First Quarter 2023
2023-04-11 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 9, 2023
2023-03-01 11:59 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2022
2023-02-01 22:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, March 1, 2023
2022-12-13 22:00 ET
Novanta to Present at the CJS Securities 23rd Annual New Ideas for the New Year Investor Conference on Wednesday, January 11, 2023
2022-12-12 22:00 ET
Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023
2022-11-08 11:59 ET
Novanta Announces Financial Results for the Third Quarter 2022
2022-10-13 21:00 ET
Novanta to Present at the Baird 2022 Global Industrial Conference on Wednesday, November 9, 2022
2022-10-10 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 8, 2022
2022-08-09 10:59 ET
Novanta Announces Financial Results for the Second Quarter 2022
2022-07-11 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 9, 2022
2022-06-16 21:00 ET
Novanta to Present at the CJS Securities 22nd Annual “New Ideas” Summer Conference on Tuesday, July 12, 2022
2022-05-12 21:00 ET
Novanta to Present at Baird's 2022 Global Consumer, Technology & Services Conference on Tuesday, June 7, 2022
2022-05-11 21:00 ET
Novanta to Present at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022
2022-05-10 10:59 ET
Novanta Announces Financial Results for the First Quarter 2022
2022-04-28 12:00 ET
Celera Motion Enhances Aura Absolute Chip Encoder Series
2022-04-11 21:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 10, 2022
2022-03-01 11:59 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2021
2022-01-14 22:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, March 01, 2022
2021-12-16 22:00 ET
Novanta to Present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, January 12, 2022
2021-12-15 03:05 ET
Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
2021-11-09 11:59 ET
Novanta Announces Financial Results for the Third Quarter 2021
2021-10-22 00:36 ET
Novanta to Present at Baird's 2021 Global Industrial Conference on Wednesday, November 10, 2021
2021-10-11 22:18 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 09, 2021
2021-09-01 18:35 ET
Novanta to Present at Baird's 2021 Global Healthcare Conference on Wednesday, September 15, 2021
2021-08-31 20:15 ET
Novanta Completes Acquisitions of SEM and ATI and Updates Financial Guidance
2021-08-10 10:59 ET
Novanta Announces Financial Results for the Second Quarter 2021
2021-07-19 13:53 ET
Harris Williams Advises ATI Industrial Automation on its Pending Sale to Novanta Inc.
2021-07-19 12:00 ET
Novanta Announces Agreement to Acquire ATI
2021-07-16 14:22 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 10, 2021
2021-07-12 12:00 ET
Novanta Announces Agreement to Acquire Schneider Electric Motion USA
2021-07-01 22:00 ET
Novanta to Present at the 21st Annual CJS Securities New Ideas Summer (Virtual) Conference on Tuesday, July 13, 2021
2021-05-19 21:00 ET
Novanta to Present at the Baird's 2021 Global Consumer, Technology & Services Conference on Tuesday, June 8, 2021
2021-05-17 14:11 ET
CORRECTING and REPLACING Novanta to Present at the William Blair's 41st Annual Growth Stock Conference on Wednesday, June 2, 2021
2021-05-11 10:59 ET
Novanta Announces Financial Results for the First Quarter 2021
2021-04-15 13:23 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 11, 2021
2021-03-23 20:15 ET
Matthijs Glastra Appointed Chairman of the Board of Directors of Novanta Inc.
2021-03-01 11:59 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2020
2021-02-02 23:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Monday, March 01, 2021
2020-12-15 22:00 ET
Novanta to Present at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021
2020-12-11 19:49 ET
Novanta to Present at the CJS Securities 21st Annual New Ideas for the New Year Conference on Wednesday, January 13, 2021
2020-11-10 11:59 ET
Novanta Announces Financial Results for the Third Quarter 2020
2020-10-16 20:35 ET
Novanta to Present at the Baird Global Industrial Conference on Wednesday, November 11, 2020
2020-10-14 20:35 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 10, 2020
2020-08-14 20:35 ET
Novanta to Present at the Baird Global Healthcare Conference on Wednesday, September 9, 2020
2020-08-06 10:59 ET
Novanta Announces Financial Results for the Second Quarter 2020
2020-07-10 20:35 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Thursday, August 6, 2020
2020-06-19 20:35 ET
Novanta to Present at the CJS Securities 20th Annual New Ideas Summer Conference on Tuesday, July 14, 2020
2020-06-03 11:00 ET
Novanta to Present at the William Blair 40th Annual Growth Stock Conference on Tuesday, June 9, 2020
2020-05-12 10:59 ET
Novanta Announces Financial Results for the First Quarter 2020
2020-04-13 14:32 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 12, 2020
2020-02-26 11:59 ET
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2019
2020-01-20 21:17 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, February 26, 2020
2019-12-18 20:24 ET
Novanta to Present at the CJS Securities 20th Annual “New Ideas for the New Year” Conference on Wednesday, January 8, 2020
2019-11-05 11:59 ET
Novanta Announces Financial Results for the Third Quarter 2019
2019-10-28 19:30 ET
Novanta to Present at the Stifel 2019 Healthcare Conference on Wednesday, November 20, 2019
2019-10-15 19:42 ET
Novanta to Present at Baird’s 49th Annual Global Industrial Conference on Wednesday, November 6, 2019
2019-10-07 14:00 ET
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 5, 2019

SEC forms

Show financial reports only

SEC form 10
2026-11-09 00:00 ET
Novanta published news for 2026 q3
SEC form 8
2026-11-09 00:00 ET
Novanta published news for 2026 q3
SEC form 8
2026-11-09 00:00 ET
Novanta published news for 2026 q3
SEC form 10
2026-08-05 21:00 ET
Novanta reported for 2026 q2
SEC form 8
2026-08-05 20:50 ET
Novanta published news for 2026 q2
SEC form 8
2026-08-05 20:50 ET
Novanta published news for 2026 q2
SEC form 8
2026-06-09 10:02 ET
Novanta published news for 2026 q1
SEC form 8
2026-06-09 10:02 ET
Novanta published news for 2026 q1
SEC form 8
2026-06-09 10:02 ET
Novanta published news for 2026 q1
SEC form 8
2026-06-09 10:02 ET
Novanta published news for 2026 q1
SEC form 8
2026-06-09 10:02 ET
Novanta published news for 2026 q1
SEC form 10
2026-05-11 21:00 ET
Novanta reported for 2026 q1
SEC form 8
2026-05-11 20:45 ET
Novanta published news for 2026 q1
SEC form 8
2026-05-11 20:45 ET
Novanta published news for 2026 q1
SEC form 10
2026-02-23 16:57 ET
Novanta reported for 2025 q4
SEC form 8
2026-02-23 16:45 ET
Novanta published news for 2025 q4
SEC form 8
2026-02-23 16:45 ET
Novanta published news for 2025 q4
SEC form 10
2025-11-03 17:11 ET
Novanta reported for 2025 q3
SEC form 8
2025-11-03 17:00 ET
Novanta published news for 2025 q3
SEC form 8
2025-11-03 17:00 ET
Novanta published news for 2025 q3
SEC form 10
2025-08-05 13:31 ET
Novanta reported for 2025 q2
SEC form 8
2025-08-05 12:00 ET
Novanta published news for 2025 q2
SEC form 8
2025-08-05 12:00 ET
Novanta published news for 2025 q2
SEC form 10
2025-05-06 13:30 ET
Novanta reported for 2025 q1
SEC form 8
2025-05-06 12:00 ET
Novanta published news for 2025 q1
SEC form 8
2025-05-06 12:00 ET
Novanta published news for 2025 q1
SEC form 10
2025-05-06 00:00 ET
Novanta published news for 2025 q1
SEC form 10
2025-02-25 14:30 ET
Novanta published news for 2024 q4
SEC form 10
2025-02-25 00:00 ET
Novanta reported for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Novanta published news for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Novanta published news for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Novanta published news for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Novanta published news for 2024 q4
SEC form 10
2024-11-05 09:30 ET
Novanta published news for 2024 q3
SEC form 8
2024-11-05 08:00 ET
Novanta published news for 2024 q3
SEC form 8
2024-11-05 08:00 ET
Novanta published news for 2024 q3
SEC form 10
2024-08-06 09:30 ET
Novanta published news for 2024 q2
SEC form 8
2024-08-06 08:00 ET
Novanta published news for 2024 q2
SEC form 8
2024-08-06 08:00 ET
Novanta reported for 2024 q2
SEC form 10
2024-08-06 00:00 ET
Novanta published news for 2024 q2
SEC form 10
2024-05-07 09:31 ET
Novanta published news for 2024 q1
SEC form 8
2024-05-07 08:00 ET
Novanta published news for 2024 q1
SEC form 8
2024-05-07 08:00 ET
Novanta reported for 2024 q1
SEC form 10
2024-05-07 00:00 ET
Novanta published news for 2024 q1
SEC form 10
2024-02-28 09:30 ET
Novanta published news for 2023 q4
SEC form 8
2024-02-28 08:00 ET
Novanta published news for 2023 q4
SEC form 8
2024-02-28 08:00 ET
Novanta reported for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Novanta published news for 2023 q4
SEC form 10
2023-11-07 09:30 ET
Novanta published news for 2023 q3
SEC form 8
2023-11-07 08:00 ET
Novanta reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Novanta published news for 2023 q3
SEC form 10
2023-08-08 09:34 ET
Novanta reported for 2023 q2
SEC form 6
2023-08-08 08:00 ET
Novanta published news for 2023 q2
SEC form 10
2023-08-08 00:00 ET
Novanta published news for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Novanta published news for 2023 q2
SEC form 10
2023-05-09 00:00 ET
Novanta published news for 2023 q1
SEC form 8
2023-05-09 00:00 ET
Novanta published news for 2023 q1
SEC form 6
2023-03-10 16:15 ET
Novanta published news for 2022 q4
SEC form 10
2023-03-01 09:47 ET
Novanta reported for 2022 q4
SEC form 6
2023-03-01 08:02 ET
Novanta published news for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Novanta reported for 2022 q4
SEC form 8
2023-03-01 00:00 ET
Novanta reported for 2022 q4
SEC form 10
2022-11-08 09:31 ET
Novanta reported for 2022 q3
SEC form 6
2022-11-08 08:01 ET
Novanta published news for 2022 q3
SEC form 10
2022-11-08 00:00 ET
Novanta reported for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Novanta reported for 2022 q3
SEC form 10
2022-08-09 09:31 ET
Novanta reported for 2022 q2
SEC form 6
2022-08-09 08:00 ET
Novanta published news for 2022 q2
SEC form 10
2022-08-09 00:00 ET
Novanta reported for 2022 q2
SEC form 8
2022-08-09 00:00 ET
Novanta reported for 2022 q2
SEC form 6
2022-07-26 16:15 ET
Novanta published news for 2022 q2
SEC form 6
2022-07-11 16:16 ET
Novanta published news for 2022 q2
SEC form 6
2022-06-28 16:30 ET
Novanta published news for 2022 q1
SEC form 6
2022-05-16 16:30 ET
Novanta published news for 2022 q1
SEC form 10
2022-05-10 09:37 ET
Novanta reported for 2022 q1
SEC form 6
2022-05-10 08:00 ET
Novanta published news for 2022 q1
SEC form 10
2022-05-10 00:00 ET
Novanta reported for 2022 q1
SEC form 8
2022-05-10 00:00 ET
Novanta reported for 2022 q1
SEC form 6
2022-04-08 15:19 ET
Novanta published news for 2022 q1
SEC form 6
2022-03-15 16:29 ET
Novanta published news for 2021 q4
SEC form 10
2022-03-01 09:29 ET
Novanta published news for 2021 q4
SEC form 6
2022-03-01 07:58 ET
Novanta published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Novanta published news for 2021 q4
SEC form 8
2022-03-01 00:00 ET
Novanta published news for 2021 q4
SEC form 6
2021-11-12 16:15 ET
Novanta published news for 2021 q3
SEC form 10
2021-11-09 09:32 ET
Novanta published news for 2021 q3
SEC form 6
2021-11-09 07:58 ET
Novanta published news for 2021 q3
SEC form 10
2021-11-09 00:00 ET
Novanta published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Novanta published news for 2021 q3
SEC form 6
2021-10-07 16:23 ET
Novanta published news for 2021 q3
SEC form 6
2021-08-31 16:25 ET
Novanta published news for 2021 q2
SEC form 10
2021-08-10 09:31 ET
Novanta published news for 2021 q2
SEC form 6
2021-08-10 08:00 ET
Novanta published news for 2021 q2
SEC form 10
2021-08-10 00:00 ET
Novanta published news for 2021 q2
SEC form 8
2021-08-10 00:00 ET
Novanta published news for 2021 q2
SEC form 6
2021-07-19 09:00 ET
Novanta published news for 2021 q2
SEC form 6
2021-07-12 08:33 ET
Novanta published news for 2021 q2
SEC form 6
2021-05-14 17:52 ET
Novanta published news for 2021 q1
SEC form 10
2021-05-11 09:29 ET
Novanta published news for 2021 q1
SEC form 6
2021-05-11 07:57 ET
Novanta published news for 2021 q1
SEC form 10
2021-05-11 00:00 ET
Novanta published news for 2021 q1
SEC form 8
2021-05-11 00:00 ET
Novanta published news for 2021 q1
SEC form 6
2021-04-16 16:05 ET
Novanta published news for 2021 q1
SEC form 6
2021-04-06 13:22 ET
Novanta published news for 2021 q1
SEC form 6
2021-03-26 10:50 ET
Novanta published news for 2020 q4
SEC form 6
2021-03-23 16:56 ET
Novanta published news for 2020 q4
SEC form 10
2021-03-01 09:55 ET
Novanta published news for 2020 q4
SEC form 6
2021-03-01 07:49 ET
Novanta published news for 2020 q4
SEC form 6
2020-12-11 09:55 ET
Novanta published news for 2020 q3
SEC form 10
2020-11-10 09:31 ET
Novanta published news for 2020 q3
SEC form 6
2020-11-10 07:50 ET
Novanta published news for 2020 q3